Resultados: 2

    Guideline No 427: folic acid and multivitamin supplementation for prevention of folic acid–sensitive congenital anomalies

    J. obstet. gynaecol. Can; 44 (6), 2022
    To provide updated guidance on pre-conception folic acid and multivitamin supplementation for primary and secondary (recurrence) prevention of neural tube defects and other folate-sensitive congenital anomalies. Women aged 12-45 years who could become pregnant should be aware of the risk of serious birth...

    Guideline No. 410: prevention, screening, diagnosis, and pregnancy Management for fetal neural tube defects

    J. obstet. gynaecol. Can; 43 (1), 2021
    This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population: Women who are pregnant or may become pregnant. Neural tube defect screening should be offered to all pregnant women. For preven...